• Oxandrolone
• Testosterone
• Stanozolol / Boldenone
• Methyltestosterone
• Others

• Oral
• Injectable
• Transdermal Delivery Systems
• Others
• Veterinary
• Medical
• Non-Medical
• Others
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Anabolic Steroids Market Snapshot
Chapter 4. Global Anabolic Steroids Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter’s Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ Mn), 2026–2035
4.8. Global Anabolic Steroids Market Penetration & Growth Prospect Mapping (US$ Mn), 2025–2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/Impact of AI on Anabolic Steroids Industry Trends
Chapter 5. Anabolic Steroids Market Segmentation 1: By Compound Type, Estimates & Trend Analysis
5.1. Market Share by Compound Type, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following Compound Type:
5.2.1. Oxandrolone
5.2.2. Testosterone
5.2.3. Stanozolol / Boldenone
5.2.4. Methyltestosterone
5.2.5. Others
Chapter 6. Anabolic Steroids Market Segmentation 2: By Route of Administration, Estimates & Trend Analysis
6.1. Market Share by Route of Administration, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following Route of Administration:
6.2.1. Oral
6.2.2. Injectable
6.2.3. Transdermal Delivery Systems
6.24. Others
Chapter 7. Anabolic Steroids Market Segmentation 3: By End-User, Estimates & Trend Analysis
7.1. Market Share by End-User, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following End-User:
7.2.1. Veterinary
7.2.2. Medical
7.2.3. Non-Medical
7.2.4. Others
Chapter 8. Anabolic Steroids Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Anabolic Steroids Market Regional Snapshot, 2025 & 2035
8.2. North America
8.2.1. North America Anabolic Steroids Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.2.1.1. United States
8.2.1.2. Canada
8.2.2. North America Anabolic Steroids Market Revenue Estimates by Compound Type, 2022–2035
8.2.3. North America Anabolic Steroids Market Revenue Estimates by Route of Administration, 2022–2035
8.2.4. North America Anabolic Steroids Market Revenue Estimates by End-User, 2022–2035
8.2.5. North America Market Analysis
8.3. Europe
8.3.1. Europe Anabolic Steroids Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.3.1.1. Germany
8.3.1.2. United Kingdom
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Anabolic Steroids Market Revenue Estimates by Compound Type, 2022–2035
8.3.3. Europe Anabolic Steroids Market Revenue Estimates by Route of Administration, 2022–2035
8.3.4. Europe Anabolic Steroids Market Revenue Estimates by End-User, 2022–2035
8.3.5. Europe Market Analysis
8.4. Asia Pacific
8.4.1. Asia Pacific Anabolic Steroids Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.4.1.1. China
8.4.1.2. Japan
8.4.1.3. India
8.4.1.4. South Korea
8.4.1.5. South East Asia
8.4.1.6. Rest of Asia Pacific
8.4.2. Asia Pacific Anabolic Steroids Market Revenue Estimates by Compound Type, 2022–2035
8.4.3. Asia Pacific Anabolic Steroids Market Revenue Estimates by Route of Administration, 2022–2035
8.4.4. Asia Pacific Anabolic Steroids Market Revenue Estimates by End-User, 2022–2035
8.4.5. Asia Pacific Market Analysis
8.5. Latin America
8.5.1. Latin America Anabolic Steroids Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.5.1.1. Brazil
8.5.1.2. Argentina
8.5.1.3. Mexico
8.5.1.4. Rest of Latin America
8.5.2. Latin America Anabolic Steroids Market Revenue Estimates by Compound Type, 2022–2035
8.5.3. Latin America Anabolic Steroids Market Revenue Estimates by Route of Administration, 2022–2035
8.5.4. Latin America Anabolic Steroids Market Revenue Estimates by End-User, 2022–2035
8.5.5. Latin America Market Analysis
8.6. Middle East & Africa
8.6.1. Middle East & Africa Anabolic Steroids Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.6.1.1. GCC Countries
8.6.1.2. South Africa
8.6.1.3. Rest of Middle East & Africa
8.6.2. Middle East & Africa Anabolic Steroids Market Revenue Estimates by Compound Type, 2022–2035
8.6.3. Middle East & Africa Anabolic Steroids Market Revenue Estimates by Route of Administration, 2022–2035
8.6.4. Middle East & Africa Anabolic Steroids Market Revenue Estimates by End-User, 2022–2035
8.6.5. Middle East & Africa Market Analysis
Chapter 9. Competitive Landscape
9.1. Major Mergers, Acquisitions & Strategic Alliances
9.2. Company Profiles
9.2.1. Pfizer Inc.
9.2.2. Sun Pharmaceutical Industries
9.2.3. Cipla Ltd
9.2.4. Hikma Pharmaceuticals
9.2.5. Bayer AG
9.2.6. AbbVie Inc.
9.2.7. Teva Pharmaceutical Industries
9.2.8. Ferring Pharmaceuticals
9.2.9. Endo International
9.2.10. Lupin Ltd
9.2.11. Zydus Lifesciences
9.2.12. Perrigo Company
9.2.13. Mylan
9.2.14. Aspen Pharmacare
9.2.15. Others
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.